Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2881 of 5804
-
Experimental cancer drug JSI-1187 tested in early trial
Disease control TerminatedThis is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.
Phase: PHASE1 • Sponsor: JS InnoPharm, LLC • Aim: Disease control
Last updated Jun 26, 2026 12:40 UTC
-
New MRI technique sharpens diagnosis of swollen optic nerve
Diagnosis CompletedThe presence of optic disc swelling at the fundus is a non-specific clinical sign that can occur in many ophthalmologic, neuro-ophthalmologic or encephalic pathologies. The diagnostic range is vast, including inflammatory pathologies of the optic nerve, infiltrative or compressiv…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Phone coaching may ease fatigue after breast cancer
Symptom relief CompletedThe primary objective of MEDEA is to compare the effect of a personalised telephone-based health education weight loss program based on motivational coaching, exercise and diet versus a standard health educational program control on fatigue of overweight or obese BC patients (as …
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
What happens to severe COVID-19 survivors after the ICU?
Knowledge-focused OngoingMany of the patients hospitalized for a severe form of SARSCoV-2 respiratory impairment require prolonged intensive care that can be complicated in the short term, In the medium and long term, physical and psychological sequelae can affect patients' quality of life and prevent a …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can therapy cut opioid use in chronic pain? new study explores how.
Knowledge-focused CompletedThis project will increase our understanding of the mechanisms underlying changes in opioid medication use associated with three psychosocial chronic pain (CP) treatments. These treatments are: (1) Cognitive Therapy (CT), (2) Mindfulness Meditation (MM), and (3) Behavioral Activa…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can smarter monitoring of pancreatic cysts prevent cancer?
Knowledge-focused Recruiting nowThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk de…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Cash for clean breath: can remote monitoring help beat alcohol addiction?
Disease control OngoingDirectly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this study is to…
Phase: NA • Sponsor: Mikhail N Koffarnus • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Cancer drug ixazomib tested as potential MS treatment
Disease control Recruiting nowThe study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS). Participants will receive either ixazomib capsules or placebo capsules for up to 24 months.
Phase: PHASE1 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 26, 2026 13:46 UTC
-
Spinal fluid clues may unlock MS diagnosis and prognosis
Diagnosis CompletedTo determine if biomarker-based CSF testing is reliably detecting differences between patients with Multiple Sclerosis (MS), different MS-subtypes, and other central nervous system (CNS) diseases. This study will also look to identify biomarkers that could be used for the predict…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 15:35 UTC
-
Migraine drug trial for kids halted early – what we know
Symptom relief TerminatedThe reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can we predict who wakes up? new study seeks answers
Knowledge-focused Recruiting nowThe study aims to identify factors that predict the medium and long-term outcome of patients with disorders of consciousness (DOC) undergoing early neurological rehabilitation. In this prospective, observational study, 130 DOC patients are going to be included (36 months). At st…
Sponsor: BDH-Klinik Hessisch Oldendorf • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:11 UTC
-
New model could spare prostate cancer patients unnecessary surgery
Knowledge-focused CompletedRadical prostatectomy (RP) represents one treatment option for clinically localized prostate cancer (PCa). The most updated guidelines of the European Association of Urology indicate the need to perform ePLND in patients with a lymph node invasion (LNI) risk \>5% according to the…
Sponsor: Francesco Montorsi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Could a common arthritis drug ease tough myasthenia gravis?
Disease control CompletedThis is a 6 month study that will evaluate the efficacy of 5mg tofacitinib tablet taken twice a day in patients with refractory myasthenia gravis. Twenty adult participants will receive a four month treatment of tofacitinib followed by elution for one month.
Phase: EARLY_PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:36 UTC
-
Remote fitness program aims to keep cancer patients healthy while social distancing
Symptom relief CompletedTrial Phase: Phase III: Interventional Trial: Virtual clinics to deliver universal interventions to maintain and improve physical health, nutritional state and psychological wellbeing in people with cancer who are following social distancing guidance: A COVID-19 targeted trial. …
Phase: NA • Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New Drug-Coated membrane targets sarcoma after surgery
Disease control CompletedThis is an open label, first-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma after surgery. The trial will be conducted in 3 dose-escalation cohorts (3 patients eac…
Phase: PHASE1 • Sponsor: CEBIOTEX • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart bypass drug showdown: which pill keeps arteries open longest?
Disease control CompletedThe Pilot study will be a single-center, randomized, open-label, active-controlled trial. After CABG surgery using Radial Artery Grafts (RA-CABG) and signing the informed consent, all patients will be screened according to the inclusion and exclusion criteria. Estimated 150 patie…
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill could replace eye injections for Diabetes-Related vision loss
Disease control Recruiting nowThis is an open label dose-escalation study to evaluate the safety and treatment benefits of MS-553 in treatment-naive diabetic retinopathy patients with central involved macular edema. Fifteen subjects with diabetic macular edema will be enrolled into each of three dose cohorts …
Phase: PHASE1 • Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can your genes predict fatty liver complications?
Knowledge-focused Recruiting nowNAFLD is most frequently linked to excess adiposity, insulin resistance and cardiometabolic risk factors, it has become the leading cause of liver disease worldwide, and is associated with increased mortality due to multiple causes. HFC has a strong genetic component and the inve…
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New eye implant could replace drops after retina surgery
Symptom relief Recruiting nowThis study will assess the control of inflammation at days 1, 7, 14, and 21 days following the vitreoretinal surgical procedure analyzing two randomized study arms: Intracanalicular dexamethasone insert group or topical steroid drop group. Patients must be 18 years of age and ol…
Phase: PHASE4 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Could a single pill before surgery cut opioid use after kidney stone treatment?
Symptom relief CompletedThis is a randomized, placebo-controlled, double-blinded study examining the use of perioperative pregabalin in ureteroscopy with stent placement. Ureteroscopy is typically performed for kidney or ureteral stones, but may be performed for other reasons such as for the diagnosis a…
Phase: PHASE2, PHASE3 • Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC